Mass cytometry panel optimization through the designed distribution of signal interference
- 15 September 2016
- journal article
- research article
- Published by Wiley in Cytometry Part A
- Vol. 91 (1) , 39-47
Abstract
Mass cytometry is capable of measuring more than 40 distinct proteins on individual cells making it a promising technology for innovating biomarker discovery. However, in order for this potential to be fully realized, best practices in panel design need to be further defined in order to achieve consistency and reproducibility in data analysis. Of particular importance are controls that reveal, and panel design principles that mitigate the effects of signal interference or overlap. We observed a disparity between the staining profiles of two noncompeting anti‐ integrin β7 mAbs and hypothesized that signal interference was responsible. A mass‐minus‐one (MMO) control was applied and demonstrated that signal overlap caused the perceived interclonal discrepancy in β7 expression. Panel redesign in consideration of mass‐cytometry specific interference dynamics dramatically improved concordance between both mAbs by redistributing background signals caused by overlap. These studies visualize how signal overlap can complicate mass cytometry data interpretation and demonstrate how the rational distribution of interference can greatly improve panel design and data quality. © 2016 International Society for Advancement of CytometryKeywords
This publication has 27 references indexed in Scilit:
- Quantifying spillover spreading for comparing instrument performance and aiding in multicolor panel designCytometry Part A, 2013
- Advances in Human B Cell Phenotypic ProfilingFrontiers in Immunology, 2012
- Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic ContinuumScience, 2011
- Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4Blood, 2009
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel DiseasesThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platformsCytometry Part A, 2008
- Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometryJournal of Analytical Atomic Spectrometry, 2008
- Flow cytometry controls, instrument setup, and the determination of positivityCytometry Part A, 2006
- Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cellsBlood, 2003
- Compensation in Flow CytometryCurrent Protocols in Cytometry, 2002